Study To Evaluate The Pharmacokinetic, Safety And Tolerability Of Single Or Multiple Subcutaneous Doses of Recifercept
Clinical trial NCT04543344 · COMPLETED
Trial details
- NCT number
- NCT04543344
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-17
- Primary completion
- 2021-08-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.